ONCOLOGY

Clinical Summits

Lower the barrier to adopt larger CGP in Dx labs: QIAGEN Expert Talks in Europe

114 views May 27, 2022

A two-part event, the Break the Data Bottleneck Summit will explore how small to...

QIAGEN IPA

Systems analysis of cancer cell lines for drug target discovery

332 views April 25, 2022

Cancer cell line models have been a cornerstone of cancer research for decades. Cancer...

Gene Variant Databases

Access to real-world data and 2 decades of expert curation

2,602 views April 20, 2022

Across oncology applications, from research to molecular testing and pharmaceutical...

QCI Interpret for Oncology

Comparison of methods in routine somatic diagnostics

187 views April 12, 2022

Dr. Mattia Schmid from UniLabs, Switzerland compares the methods of molecular oncology...

Gene Variant Databases

Identify meaningful mutations in somatic tumor testing

919 views February 14, 2022

From Information Overload to Actionable Insights Precision medicine is transforming...

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug Target and Biomarker Investigation using OmicSoft OncoLand

334 views February 01, 2022

In this 90-minute training, attendees will learn how to use basic expression analysis...

COSMIC

Identify actionable mutations in East Asian cancer patients with COSMIC

531 views June 17, 2021

COSMIC, the Catalogue Of Somatic Mutations In Cancer...

QCI Interpret for Oncology

Gaining insights with transcriptomic profiling and mechanistic modeling

297 views June 11, 2021

In this webinar, Moritz Schütte, head of next-generation sequencing data analysis at...

QCI Interpret for Oncology

Generate oncologist-ready clinical reports from comprehensive panels

194 views June 02, 2021

Ruth Burton, Ph.D., Clinical Application Specialist, QIAGEN Digital Insights explains...

QCI Interpret for Oncology

Confidence and trust: Deliver valuable clinical insights with high-quality...

187 views June 02, 2021

Ben Turner, Director of Bioinformatics Enterprise Solutions, QIAGEN Digital Insights...

QCI Interpret for Oncology

Going beyond: Molecular evidence for off-label therapy use

129 views June 02, 2021

Kathryn Bungartz, Ph.D., Associate StaffField Application Scientist, QIAGEN Digital...

Clinical and Translational

Oncology variant interpretation just got more precise

360 views May 10, 2021

Competing to offer a comprehensive genomic profiling service for solid or hematology...